Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Azathioprine (Primary) ; Pegloticase (Primary)
- Indications Gout
- Focus Therapeutic Use
- Acronyms TRIPLE
- 10 Nov 2017 Planned number of patients changed from 87 to 177.
- 08 Nov 2017 Results (n=47) presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 06 Nov 2017 Planned End Date changed from 1 Apr 2019 to 1 Apr 2020.